BEIJING, Aug. 20 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial results for the fourth fiscal quarter ("4Q FY2008") and fiscal year ended March 31, 2009 ("FY2008") and the first fiscal quarter ("1Q FY2009") ended June 30, 2009 before the U.S. market opens on September 1, 2009. The Company's 2009 fiscal year ends on March 31, 2010.
The Company's CEO, Mr. Xiaodong Wu, and CFO, Mr. Sam Tsang, will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on September 1, 2009 (8:00 p.m. on September 1, 2009 Beijing/Hong Kong time).
Conference Call The dial-in details for the live conference call are as follows: -- U.S. Toll Free Number 1-800-291-9234 -- International Dial-in Number 1-617-614-3923 Passcode: CMEDCALL
A live webcast of the conference call will be available on http://ir.chinameditech.com .
A replay of this webcast will be available for one month on this website.
A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on September 2, 2009. The dial-in details for the replay are as follows:
-- U.S. Toll Free Number 1-888-286-8010 -- International Dial-in Number 1-617-801-6888 Passcode: 92901366
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .
For more information, please contact: Winnie Yam Tel: +852-2511-9808 Email: IR@chinameditech.com
|SOURCE China Medical Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved